Commentary: Can we depend on the point-of-care rapid antigen testing for SARS-CoV-2 for routine ophthalmic procedures and high volume ophthalmic settings?
- PMID: 35502069
- PMCID: PMC9333021
- DOI: 10.4103/ijo.IJO_757_22
Commentary: Can we depend on the point-of-care rapid antigen testing for SARS-CoV-2 for routine ophthalmic procedures and high volume ophthalmic settings?
Conflict of interest statement
None
Comment on
-
Ophthalmology practice in COVID-19 pandemic: Performance of rapid antigen test versus real time-reverse transcription polymerase chain reaction in a tertiary eye care institute in South India.Indian J Ophthalmol. 2022 May;70(5):1761-1765. doi: 10.4103/ijo.IJO_21_22. Indian J Ophthalmol. 2022. PMID: 35502068 Free PMC article.
References
-
- Advisory_for_rapid_antigen_test14062020.pdf. [Last accessed on 2022 Mar 03]. Available from: https://www.icmr.gov.in/pdf/covid/strategy/Advisory_for_rapid_antigen_te... .
-
- Tripathy D, Roy AK, Khanna RC, Jalali S, Panigrahy B, Parija DC, et al. Point-of-care rapid antigen testing for COVID-19 at a tertiary eye care facility: Role in commencement of elective surgeries, contact tracing and implementation of back-to-work policy. Indian J Ophthalmol. 2021;69:964–70. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
